Search - tctmd.com

Displaying 801 - 820 of 1032

Sort: Relevancy | Date

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Todd Neale

November 17, 2014

News Daily News

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

November 06, 2014

News Daily News

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

November 06, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

Presentation

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Presenter: C.V. Bourantas

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

Presentation Cardiovascular Interventions 2014

The Next Wave of Stent Design II: Bioresorbable Polymers

Presenter: Matthew J. Price

October 24, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

News Industry News

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

September 18, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

Con: The Psychological Attraction Will Pass When the Data Emerges!

Presenter: Daniel I. Simon

September 16, 2014

Presentation TCT 2014

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

Presenter: Stephan Achenbach

September 16, 2014

Presentation TCT 2014

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Vasileios Panoulas

September 16, 2014

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

Presentation TCT 2014

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Ulrich Hink

September 16, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Imaging to Guide BRS: Nice to Have or Must Have?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Evelyn S. Regar

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Jonathan M. Hill

September 16, 2014

Presentation TCT 2014

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Azeem Latib

September 16, 2014

Advertisement

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

The Next Wave of Stent Design II: Bioresorbable Polymers

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

Con: The Psychological Attraction Will Pass When the Data Emerges!

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Imaging to Guide BRS: Nice to Have or Must Have?

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content